Similar articles for PMID: 11079506

Year	Number of Results
1975	1
1979	1
1980	1
1981	1
1982	2
1983	3
1985	2
1986	2
1987	3
1988	1
1989	9
1990	6
1991	2
1992	2
1993	1
1994	4
1995	1
1996	1
1997	5
1998	5
1999	4
2000	5
2001	2
2002	6
2004	3
2007	1
2008	1
2010	2
2015	2
2019	1
2020	2
2024	0

1

Evaluating dementia using PET: how do we put into clinical perspective what we know to date?

Silverman DH, Phelps ME. Silverman DH, et al. J Nucl Med. 2000 Nov;41(11):1929-32. J Nucl Med. 2000. PMID: 11079506 Free article. No abstract available.

2

FDG PET imaging in patients with pathologically verified dementia.

Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, Coleman RE. Hoffman JM, et al. J Nucl Med. 2000 Nov;41(11):1920-8. J Nucl Med. 2000. PMID: 11079505 Free article.

3

Functional imaging in dementia: an overview.

Jagust WJ. Jagust WJ. J Clin Psychiatry. 1994 Nov;55 Suppl:5-11. J Clin Psychiatry. 1994. PMID: 7989292 Review.

4

A tabulated summary of the FDG PET literature.

Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. Gambhir SS, et al. J Nucl Med. 2001 May;42(5 Suppl):1S-93S. J Nucl Med. 2001. PMID: 11483694 Free article. Review. No abstract available.

5

Determinations of cerebral glucose utilization in dementia using positron emission tomography.

Kuhl DE, Metter EJ, Riege WH, Hawkins RA. Kuhl DE, et al. Dan Med Bull. 1985 Feb;32 Suppl 1:51-5. Dan Med Bull. 1985. PMID: 3872772 No abstract available.

6

A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.

Morbelli S, Garibotto V, Van De Giessen E, Arbizu J, Chételat G, Drezgza A, Hesse S, Lammertsma AA, Law I, Pappata' S, Payoux P, Pagani M; European Association of Nuclear Medicine. Morbelli S, et al. Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1487-91. doi: 10.1007/s00259-015-3098-2. Eur J Nucl Med Mol Imaging. 2015. PMID: 26067090 Review. No abstract available.

7

Positron emission tomography in dementia.

Santens P, Petit H. Santens P, et al. Acta Neurol Belg. 1997 Sep;97(3):192-5. Acta Neurol Belg. 1997. PMID: 9345592 Review.

8

Positron emission tomography as an imaging tool in psychiatric disorders.

Heiss WD, Pawlik G, Herholz K, Szelies B, Wienhard K. Heiss WD, et al. Psychiatry Res. 1989 Sep;29(3):351-2. doi: 10.1016/0165-1781(89)90086-3. Psychiatry Res. 1989. PMID: 2532752 No abstract available.

9

18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.

Farkas T, Ferris SH, Wolf AP, De Leon MJ, Christman DR, Reisberg B, Alavi A, Fowler JS, George AE, Reivich M. Farkas T, et al. Am J Psychiatry. 1982 Mar;139(3):352-3. doi: 10.1176/ajp.139.3.352. Am J Psychiatry. 1982. PMID: 6977276 No abstract available.

10

Characteristics of cerebral glucose utilization in dementia.

Matsuzawa T, Matsui H, Meguro K, Ueda M, Yamada K, Yamaguchi T, Itoh M, Hatazawa J, Kinomura S. Matsuzawa T, et al. Sci Rep Res Inst Tohoku Univ Med. 1990 Dec;37(1-4):11-21. Sci Rep Res Inst Tohoku Univ Med. 1990. PMID: 2103655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

81 results

Results by year